Evoke Pharma
EVOK
EVOK
25 hedge funds and large institutions have $8.74M invested in Evoke Pharma in 2020 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
0.01% more ownership
Funds ownership: 0.04% → 0.05% (+0.01%)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Holders
25
Holding in Top 10
–
Calls
$1.36M
Puts
$825K
Top Buyers
| 1 | +$1.77M | |
| 2 | +$312K | |
| 3 | +$287K | |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$108K |
| 5 |
Renaissance Technologies
New York
|
+$105K |
Top Sellers
| 1 | -$333K | |
| 2 | -$161K | |
| 3 | -$125K | |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$22K |
| 5 |
UCFA
United Capital Financial Advisors
Irving,
Texas
|
-$7.49K |